Related Experiment Video
Updated: Jul 8, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
[Inflammatory bowel disease--the role and issue of glucocorticoid]
1Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical College.
Abstract:
We herein reviewed the clinical applications of glucocorticoid (GC) hormones to inflammatory bowel disease (IBD). In the therapeutic strategy for active ulcerative colitis, topical/systemic GC administration is still central during these fifty years. However, non -responders to GC are present at 30-40% of the active UC patients. We analyzed the expression of GC receptor isoform, namely hGRbeta, in peripheral blood mononuclear cells, and suggest the possibility that expression of hGRbeta, induced by proinflammatory cytokine IL-18, is closely related GC resistance in UC.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Crohn's Disease
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
